89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer

Verhoeff, SR; van de Donk, PP; Aarntzen, EHJG; Oosting, SF; Brouwers, AH; Miedema, IHC; Voortman, J; van Oordt, WCMV; Boellaard, R; Vriens, D; Slingerland, M; Hermsen, R; van Engen-van Grunsven; Heskamp, S; van Herpen, CML

van Herpen, CML (通讯作者)，Radboud Univ Nijmegen, Dept Med Oncol, Med Ctr, Nijmegen, Netherlands.

JOURNAL OF NUCLEAR MEDICINE, 2022; 63 (10): 1523

Abstract

In this PD-L1 ImagiNg to prediCt durvalumab treatment response in SCCHN (PINCH) study, we performed 89Zr-DFO-durvalumab (anti- PD-L1 [programmed death......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索